Drug‐induced EEG pattern predicts effectiveness of ketamine in treating refractory status epilepticus

Refractory status epilepticus (RSE) can lack overt clinical manifestation and is usually treated with continuous infusion of intravenous anesthetic drugs (IVADs), where the use of continuous electroencephalography (cEEG) is imperative. Ketamine has recently been shown to be effective in the treatment of RSE. We retrospectively review a cohort of 11 patients receiving ketamine as part of their treatment regimen for RSE. We report on the presence of a characteristic EEG rhythm consisting of a generalized archiform theta to beta rhythms (7–20 Hz) appearing after ketamine administration. This pattern was seen in five patients, four of whom achieved successful resolution of RSE. Ketamine‐induced EEG pattern may serve as a biomarker predictive of successful treatment outcome in RSE.

[1]  Jan Claassen,et al.  Refractory status epilepticus: frequency, risk factors, and impact on outcome. , 2002, Archives of neurology.

[2]  P. White,et al.  Ketamine--its pharmacology and therapeutic uses. , 1982, Anesthesiology.

[3]  D. Naylor,et al.  Trafficking of NMDA receptors during status epilepticus: Therapeutic implications , 2013, Epilepsia.

[4]  L. Mirabile,et al.  Efficacy and safety of ketamine in refractory status epilepticus in children , 2012, Neurology.

[5]  Tai-Yuan Chen,et al.  Oral ketamine controlled refractory nonconvulsive status epilepticus in an elderly patient , 2011, Seizure.

[6]  Jan Claassen,et al.  Treatment of status epilepticus: a survey of neurologists , 2003, Journal of the Neurological Sciences.

[7]  A. Yli-Hankala,et al.  Increase in high frequency EEG activity explains the poor performance of EEG spectral entropy monitor during S-ketamine anesthesia , 2006, Clinical Neurophysiology.

[8]  E. Wijdicks.  The multifaceted care of status epilepticus , 2013, Epilepsia.

[9]  Paul F. White,et al.  Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man , 1987, Journal of Pharmacokinetics and Biopharmaceutics.

[10]  K. Kelly,et al.  Ketamine use in the treatment of refractory status epilepticus , 2013, Epilepsy Research.

[11]  Simon Shorvon,et al.  The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. , 2011, Brain : a journal of neurology.

[12]  F. Zeiler,et al.  The Ketamine Effect on ICP in Traumatic Brain Injury , 2014, Neurocritical Care.

[13]  H. Prüss,et al.  Ketamine successfully terminates malignant status epilepticus , 2008, Epilepsy Research.

[14]  K. Tschaikowsky,et al.  Changes in the EEG power spectrum after midazolam anaesthesia combined with racemic or S – (+) ketamine , 1994, Acta anaesthesiologica Scandinavica.

[15]  J. Szaflarski,et al.  Intravenous ketamine for the treatment of refractory status epilepticus: A retrospective multicenter study , 2013, Epilepsia.